Skip to content

Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement

Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04006899
Enrollment
5
Registered
2019-07-05
Start date
2018-06-20
Completion date
2019-05-30
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Device

Keywords

Bioelectrical Impedance spectroscopy, Body compositions, Segmental Bioelectrical impedance spectroscopy

Brief summary

A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric current.

Detailed description

The measurement of individual segments, instead of the body as a whole, with BIA has not been fully explored. The prototype device is capable of directly measuring multiple body segments (arm, trunk, and leg) simultaneously, and the final version will be able to provide composition about each segment and the body as a whole. Current devices on the market are not capable of this. The reference devices will be used to measure segments as well, and the raw measurements will be compared. The Multiscan 5000 provides segmental body composition for the arm or leg, but requires measuring it separately. The SFB7 is designed only for measuring the whole body, but the raw impedance measurement data from the SFB7 can be used for comparison, as the impedance magnitudes of individual segments will be within its measurement range. The Seca 514 doesn't directly measure segments, but it can provide segmental data by measuring from hand to foot, then from hand to hand, and finally from foot to foot. It then uses these measurements, and assumptions about the subject to provide segmental composition data.

Interventions

DEVICEBioelectrical Impedance Monitor

Subjects had been under the test of three commercially available devices and the device that the investigators had developed.

Sponsors

Jun Choi
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Students from Georgia Southern University

Design outcomes

Primary

MeasureTime frameDescription
Impedance values from each devicesOne year IRB periodBioelectrical impedance values from three devices were measured and recorded.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026